Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1974 2
1975 2
1976 2
1977 4
1978 3
1979 5
1980 3
1981 1
1982 2
1983 8
1984 4
1985 4
1986 3
1987 3
1988 1
1989 7
1990 2
1991 4
1992 5
1993 4
1994 8
1995 8
1996 6
1997 4
1998 1
1999 6
2000 3
2001 6
2002 8
2003 2
2004 2
2005 8
2006 4
2007 5
2008 4
2009 2
2010 4
2011 5
2012 3
2013 2
2014 4
2015 4
2016 4
2018 2
2020 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

169 results
Results by year
Filters applied: . Clear all
Page 1
Conservative iron chelation for neurodegenerative diseases such as Parkinson's disease and amyotrophic lateral sclerosis.
Devos D, Cabantchik ZI, Moreau C, Danel V, Mahoney-Sanchez L, Bouchaoui H, Gouel F, Rolland AS, Duce JA, Devedjian JC; FAIRPARK-II and FAIRALS-II studygroups. Devos D, et al. Among authors: cabantchik zi. J Neural Transm (Vienna). 2020 Feb;127(2):189-203. doi: 10.1007/s00702-019-02138-1. Epub 2020 Jan 7. J Neural Transm (Vienna). 2020. PMID: 31912279 Review.
Intracellular labile iron.
Breuer W, Shvartsman M, Cabantchik ZI. Breuer W, et al. Among authors: cabantchik zi. Int J Biochem Cell Biol. 2008;40(3):350-4. doi: 10.1016/j.biocel.2007.03.010. Epub 2007 Mar 19. Int J Biochem Cell Biol. 2008. PMID: 17451993 Review.
Iron as a therapeutic target for Parkinson's disease.
Moreau C, Duce JA, Rascol O, Devedjian JC, Berg D, Dexter D, Cabantchik ZI, Bush AI, Devos D; FAIRPARK-II study group. Moreau C, et al. Among authors: cabantchik zi. Mov Disord. 2018 Apr;33(4):568-574. doi: 10.1002/mds.27275. Epub 2018 Jan 30. Mov Disord. 2018. PMID: 29380903 Review. No abstract available.
The Labile Side of Iron Supplementation in CKD.
Slotki I, Cabantchik ZI. Slotki I, et al. Among authors: cabantchik zi. J Am Soc Nephrol. 2015 Nov;26(11):2612-9. doi: 10.1681/ASN.2015010052. Epub 2015 May 21. J Am Soc Nephrol. 2015. PMID: 25999405 Free PMC article. Review.
Erythrocyte membrane transport.
Cabantchik ZI. Cabantchik ZI. Novartis Found Symp. 1999;226:6-16; discussion 16-9. doi: 10.1002/9780470515730.ch2. Novartis Found Symp. 1999. PMID: 10645535 Review.
LPI-labile plasma iron in iron overload.
Cabantchik ZI, Breuer W, Zanninelli G, Cianciulli P. Cabantchik ZI, et al. Best Pract Res Clin Haematol. 2005 Jun;18(2):277-87. doi: 10.1016/j.beha.2004.10.003. Best Pract Res Clin Haematol. 2005. PMID: 15737890 Review.
Iron and oxidative stress in cardiomyopathy in thalassemia.
Berdoukas V, Coates TD, Cabantchik ZI. Berdoukas V, et al. Among authors: cabantchik zi. Free Radic Biol Med. 2015 Nov;88(Pt A):3-9. doi: 10.1016/j.freeradbiomed.2015.07.019. Epub 2015 Jul 26. Free Radic Biol Med. 2015. PMID: 26216855 Review.
Intracellular and extracellular labile iron pools.
Cabantchik ZI, Kakhlon O, Epsztejn S, Zanninelli G, Breuer W. Cabantchik ZI, et al. Adv Exp Med Biol. 2002;509:55-75. doi: 10.1007/978-1-4615-0593-8_4. Adv Exp Med Biol. 2002. PMID: 12572989 Review. No abstract available.
169 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page